Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Shaky Q1 For Lupin But Upbeat On FDA Generics Reform, Biosimilars

Aug 03 2017

• By Anju Ghangurde

Pharma pills

Related Content

Implementing User Fees Should Be Lighter Lift For FDA This Time Around; Bill Heads To White House

Aug 03 2017

Breakthrough-Style Program For ANDAs Added To House User Fee Bill

May 19 2017

Generic Industry Gets 267 Reasons From FDA To Pursue ANDA Development

Jun 28 2017

Related Companies

Lupin Limited

Amgen, Inc.

Additional Topics

India Asia Pacific Strategy Sales & Earnings Generic Drugs Biosimilars Commercial BioPharmaceutical

More from India

More from Focus On Asia

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window